The protein-energy wasting syndrome, characterized by a decline in body protein mass and energy reserves, including muscle and fat wasting and visceral protein mass pool concentration, is often seen in chronic kidney disease (CKD) patients and is a strong predictor of adverse outcomes. The prevalence of the syndrome increases with the progression of CKD, in part because of the activation of pro-inflammatory processes, the hypercatabolic state and the decreased appetite. Worsening uremia also renders CKD patients vulnerable to potentially deleterious effects of uncontrolled diets (e.g. higher phosphorous and potassium burden).

A product addressing these needs is currently being developed.

Clinical research of the past decade has shown that specific conditions require specific medical nutrition. According to these scientific findings and based on an approach focusing on patients and conditions we are currently working to identify the specific nutritional needs of many different illnesses in order to develop products which address these needs. 

To read more about our development strategy and on-going research, click here.

Ikizler et al. Am J Kidney Dis 2020;76(Suppl 1):S1-S107.
Fiaccadori et al. Clin Nutr 2021;40:1644-1668.
Rangel-Huerta. et al. Br J Nutr 2012;107:S159-70.